Higgins Jack has filed 18 insider transactions across 1 company since December 2023.
Most recent transaction: a gift of 6291 shares of Immunome Inc. ($IMNM) on March 30, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 6291 | $0.00 | 34,438.0000 | 91,710,277 | 15.45% | 0.01% |
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.52% | 0.00% |
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 42,729.0000 | 91,710,277 | 2.29% | 0.00% |
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.52% | 0.00% |
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 41,729.0000 | 91,710,277 | 2.34% | 0.00% |
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.52% | 0.00% |
| Dec. 19, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 1000 | $0.00 | 40,729.0000 | 91,710,277 | 2.40% | 0.00% |
| Sept. 10, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | M | Employee Stock option (right to buy) | 22000 | $0.00 | 151,840.0000 | 0 | 12.66% | 0.00% |
| Sept. 10, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | M | Common Stock | 22000 | $1.35 | 40,729.0000 | 0 | 117.46% | 0.00% |
| July 29, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 196000 | $0.00 | 196,000.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | M | Common Stock | 5200 | $1.35 | 18,729.0000 | 0 | 38.44% | 0.00% |
| March 27, 2025 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | M | Employee Stock option (right to buy) | 5200 | $0.00 | 173,840.0000 | 0 | 2.90% | 0.00% |
| Aug. 15, 2024 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | M | Stock option (right to buy) | 19524 | $0.00 | 179,040.0000 | 0 | 9.83% | 0.00% |
| Aug. 19, 2024 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | G | Common Stock | 2471 | $0.00 | 13,529.0000 | 0 | 15.44% | 0.00% |
| Aug. 15, 2024 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | S | Common Stock | 3524 | $13.93 | 16,000.0000 | 0 | 18.05% | 0.00% |
| Aug. 15, 2024 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | M | Common Stock | 19524 | $1.35 | 19,524.0000 | 0 | 9999.99% | 0.00% |
| Aug. 9, 2024 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | A | Stock option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 1, 2023 | Immunome Inc. | $IMNM | Higgins Jack | Chief Scientific Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |